The Effects of an LED Face Mask & Neck and Chest Mask On Skin Health

NCT ID: NCT07025837

Last Updated: 2025-10-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-14

Study Completion Date

2025-02-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This 12-week single-group virtual study evaluates the effects of the iRESTORE Illumina LED Face Mask and Neck \& Chest Mask on skin health in adult females. Participants will use the devices daily for 10 minutes and complete scheduled surveys and photographs to assess improvements in skin appearance via both dermatologist assessment and participant perception.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Aging Sun Damaged Skin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

iRESTORE Illumina LED Device Group

All participants will use the iRESTORE LED Face Mask and Neck \& Chest Mask daily for 10 minutes each night. For the face mask, Mode 1 will be used.

Group Type EXPERIMENTAL

iRESTORE Illumina LED Face Mask and Neck & Chest Mask

Intervention Type DEVICE

A pair of light-emitting diode (LED) therapy devices designed for at-home use. The facial and neck/chest masks deliver low-level red light therapy through embedded LEDs to improve visible signs of skin aging.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iRESTORE Illumina LED Face Mask and Neck & Chest Mask

A pair of light-emitting diode (LED) therapy devices designed for at-home use. The facial and neck/chest masks deliver low-level red light therapy through embedded LEDs to improve visible signs of skin aging.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female
* Aged 25-55 years.
* Willing to follow the study protocols.
* Self-reported issues with at least two of the following: Fine lines, Wrinkles, Hyperpigmentation, Dark spots, Reduced elasticity
* Self-report concerns with at least one of the following: Crepey skin on the neck and chest, Sun damage on neck and chest
* Willing to avoid introducing any new products, prescription medications, or supplements that target skin health during the study period.
* If taking oral supplements or herbal remedies targeted at skin health and appearance, have been consistently taking these for at least 3 months prior to starting the study.
* Is willing to maintain the routine of any oral supplements or herbal remedies targeted at skin health and appearance for the duration of the study.
* Has been using the same skincare routine for at least one month prior to the study start date.
* Willing to maintain the same skincare routine and products throughout the study.
* Willing to avoid direct sun exposure during the study duration
* Willing to wear sunscreen if have to be in the sun

Exclusion Criteria

* Anyone who is extremely satisfied with their skin.
* Anyone who has any chronic health conditions such as oncological (cancer) or psychiatric disorders.
* Anyone who is planning to undergo facial treatments during the study period, including botox, dermal filler, chemical peels, etc. or has experienced any of these treatments in the last 3 months.
* Anyone diagnosed with a skin condition affecting the face and/or neck who has had an active flare-up or breakout within the last year. This includes but is not limited to acne, eczema, psoriasis, rosacea, seborrheic dermatitis, vitiligo, urticaria (hives), warts, atopic dermatitis, melasma, and contact dermatitis.
* Currently using any prescription medications that may affect the skin condition including but not limited to the following:
* Corticosteroids like prednisone, methylprednisolone
* Antipsychotics like olanzapine (Zyprexa), risperidone (Risperdal), quetiapine (Seroquel)
* SSRIs and SNRIs like fluoxetine (Prozac), sertraline (Zoloft), venlafaxine (Effexor)
* Anticonvulsants like phenytoin (Dilantin), lamotrigine (Lamictal), and carbamazepine (Tegretol)
* Antihypertensives like lisinopril (Zestril), amlodipine (Norvasc), and propranolol (Inderal)
* Antithyroid medications like Tapazole (methimazole), Propyl-Thyracil (propylthiouracil)
* Anyone with a history of skin cancer or precancerous skin lesions on the face.
* Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
* Anyone who has any known allergies to ingredients commonly found in skincare products.
* Anyone who is pregnant, breastfeeding, or trying to conceive
* Anyone who cannot/will not commit to the study protocol.
* Anyone with a history of substance abuse.
* Anyone who has undergone an invasive medical procedure in the three weeks prior to the study or has a procedure planned during the study duration.
* Anyone with a known allergic reaction to aluminum or plastics.
* Anyone who suffers from any photosensitive disorder (sensitization to light).
* Anyone with uncontrolled acne.
* Anyone taking any prescription medication, over-the-counter supplements, or herbal supplements regularly (three or more days per week) that can cause photosensitivity including but not limited to the following:
* Antibiotics like tetracyclines (e.g., doxycycline, tetracycline) or sulfonamides (e.g., Bactrim), fluoroquinolones (e.g., ciprofloxacin, levofloxacin)
* Antifungals like Griseofulvin or Vfend (voriconazole)
* Diuretics like drugs ending in -thiazides
* NSAIDs like ibuprofen and Aleve (naproxen)
* Retinoids or Vitamin A (e.g., Accutane (isotretinoin), (Retin-A) tretinoin
* Antidepressants (e.g., SSRIs, Elavil (amitriptyline), Tofranil (imipramine)
* Antihistamines like Phenergan (promethazine)
* Antimalarial medications
* Statins like Lipitor (atorvastatin), Zocor (simvastatin)
* Antiarrhythmics like Pacerone (amiodarone)
* St. John's wort
* Anyone who suffers from light-induced headaches or migraines.
* Anyone with a medical history of seizures or epilepsy triggered by light.
* Anyone with an electronic implanted device such as a defibrillator, neurostimulator, pacemaker, or ECG monitor.
* Anyone with a known history of carotid artery disease, stroke or transient ischemic attack (TIA), carotid stenosis, unstable blood pressure, easy fainting, thyroid disease, or of individuals about to undergo surgical procedures in the neck area.
* Anyone who has stopped hormonal birth control in the past month.
Minimum Eligible Age

25 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Citruslabs

INDUSTRY

Sponsor Role collaborator

Freedom Laser, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Citruslabs

Las Vegas, Nevada, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20679

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.